Donepezil (selective AChE inhibitor) and rivastigmine (pseudo-irreversible AChE and BChE inhibitor) belong to the small regimen of cholinesterase inhibitors that are used clinically as palliative AD treatment. This evidence concerns the gene ACHE and Alzheimer disease.